Pharmaceutical Preformulation: Physicochemical Properties of Excipients and Powders and Tablet Characterization

Pharmaceutical Manufacturing Handbook: Production and Processes

Volumn , Issue , 2007, Pages 879-931

  Lee, Beom Jin ^a  

^a Kangwon National University   (South Korea)

Author keywords

Drug hygroscopicity and pharmaceutical substances; Drug excipient compatibility; Pharmaceutical excipient and pharmaceutical preformulation

Indexed keywords

EID: 84872683628     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470259818.ch23     Document Type: Chapter

References (32)

1. Kibbe, A. H. (2000), Handbook of Pharmaceutical Excipients, 3rd ed., American Pharmaceutical Association and Pharmaceutical Press, London.
2. Gibson, M. (2001), Pharmaceutical Preformulation and Formulation, A Practical Guide from Candidate Drug Selection to Commercial Dosage Form, HIS Health Group, Denver, CO.
3. Allen, L. V., Popovich, N. G., and Angel, H. C. (2005), Pharmaceutical dosage forms and drug delivery systems, Lippincott Williams & Wilkins, Baltimore, MD, USA.
4. Mountfield, R. J., Senepin, S., Schleimer, M., Walter, I., and Bittner, B. (2000), Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450, Int. J. Pharm., 211, 89-92.
5. Cornaire, G., Woodley, J., Hermann, P., Cloarec, A., Arellano, C., and Houin, G. (2004), Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo, Int. J. Pharm., 278, 119-131.
6. Wang, S.-W., Monagle, J., McNulty, C., Putnam, D., and Chen, H. (2004), Determination of P-glycoprotein inhibition by excipients and their combinations using an integrated high-throughput process, J. Pharm. Sci., 93, 2755-2767.
7. Karsa, D. R., and Stephenson, R. A. (1995), Excipients and Delivery Systems for Pharmaceutical Formulations, The Royal Society of Chemistry, Cambridge, pp. 1-34.
8. Farber, L., Tardos, G. I., and Michaels, J. N. (2003), Evolution and structure of drying material bridges of pharmaceutical excipients: Studies on a microscope slide, Chem. Eng. Sci., 58, 4515-4525.
9. Cao, Q.-R., Choi, Y.-W., Cui, J.-H., and Lee, B.-J. (2005), Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen, J. Controlled Release, 108, 351-361.
10. Jackson, K., Young, D., and Pant, S. (2000), Drug-excipient interactions and their affect on absorption, PSTT, 3 (10), 336-345.
11. Patel, H., Stalcup, A., Dansereau, R., and Sakr, A. (2003), The effect of excipients on the stability of levothyroxine sodium pentahydrate tablets, Int. J. Pharm., 264, 35-43.
12. Verma, R. K., and Garg, S. (2004), Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations, J. Pharm. Biomed. Anal., 35, 449-458.
13. Young, W. R. (1990), Accelerated temperature pharmaceutical product stability determinations , Drug Dev. Ind. Pharm., 16 (4), 551-569.
14. Waterman, K. C., and Adami, R. C. (2005), Accelerated aging: Prediction of chemical stability of pharmaceuticals, Int. J. Pharm., 293, 101-125.
15. Simon, P., Veverka, M., and Okuliar, J. (2004), New screening method for the determination of stability of pharmaceuticals, Int. J. Pharm., 270, 21-26.
16. Florence, A. T. and Attwood, D. (1998), Physicochemical principles of pharmacy, 3rd ed., Macmillan, London, pp. 5-35, 101-151.
17. Hiestand, E. N. (1989), The basis for practical applications of the tableting indices, Pharm. Technol. Int., 8, 54-66.
18. Carstensen, J. T. (1993), Pharmaceutical Principles of Solid Dosage Forms, Technomic Publishing, Lancaster, PA.
19. Brittain, H. G. (1995), Physical Characterization of Pharmaceutical Solids, Marcel Dekker, New York.
20. Sinko, P. J. (2006), Physical Pharmacy and Pharmaceutical Sciences, Lippincott Williams and Wilkins, Baltimore, MD.
21. Carson, J. W. and Wilms, H. (2006), Development of an international standard for shear testing, Powder Technol., 167, 1-9.
22. Hedenus, P., Mattsson, M. S., Niklasson, G. A., Camber, O., and Ek, R. (2000), Characterization of instantaneous water absorption properties of pharmaceutical excipients, Int. J. Pharm., 141, 141-149.
23. Hasegawa, S., Hamaura, T., Furuyama, N., Kusai, A., Yonemochi, E., and Terada, K. (2005), Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method, Int. J. Pharm., 302, 103-112.
24. Mullarney, M. P., Hancock, B. C., Carlson, G. T., Ladipo D. D., and Langdon, B. A. (2003), The powder flow and compact mechanical properties of sucrose and three high-intensity sweeteners used in chewable tablets, Int. J. Pharm., 257, 227-236.
25. Meyer, K., and Zimmermann, I. (2004), Effect of glidants in binary powder mixtures, Powder Technol., 139, 40-54.
26. Hancock, B. C., and Zografi, G. (1997), Characteristics and significance of the amorphous state in pharmaceutical systems, J. Pharm. Sci., 86 (1), 1-12.
27. Willart, J., Lefebvre, J., Dan ède, F., Comini, S., Looten, P., and Descamps, M. (2005), Polymorphic transformation of the G-form of d-sorbitol upon milling: Structural and nanostructural analyses, Solid State Communi., 135 (8), 519-524.
28. Adolfsson, A., and Nystrom, C. (1996), Tablet strength, porosity, elasticity and solid state structure of tablets compressed at high loads, Int. J. Pharm., 132, 95-106.
29. Caramella, C., Colombo, P., Conte, U., Ferrari, F., and Manna, A. L. (1986), Water uptake and disintegration force measurements: Towards a general understanding of disintegration mechanism, Drug Dev. Ind. Pharm., 12, 1749-1766.
30. Pourkavoos, N., and Peck, G. E. (1993), The effect of swelling characteristics of superdisintegrants on the aqueous coating solution penetration into the tablet matrix during the film coating process, Pharm. Res., 10 (9), 1363-1371.
31. Lerk, C. F., Bolhuis, G. K., Smallenbroek, A. J., and Zuurman, K. (1982), Interaction of tablet disintegrations and magnesium stearate during mixing II. Effect on dissolution rate, Pharm. Acta Helv, 57, 282-286.
32. Gundert-Remy, U., and Moller, H. (1990), Oral Controlled Release Products, Therapeutic and Biopharmaceutical Assessment, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, Germany, pp. 155-173.